Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AIDRONE Oil
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
AIDRONE Oil is an Ayurvedic pain relief oil developed and marketed by Croise Pharma. It is formulated as a synergistic blend of traditional Ayurvedic herbal oils, including Mahanarayan Tel, Gandhpura Oil, Nirgundi Satva, Til Oil, Lavanga Oil, and Kapoor (camphor). The topical formulation is designed to provide fast-acting relief from joint pain, backache, muscular sprains, arthritis, joint stiffness, sciatica, and other painful musculoskeletal conditions. By improving peripheral blood circulation and reducing localized inflammation, AIDRONE Oil helps restore joint mobility and ease muscle stiffness.
- Brand names
- AIDRONE OilAidrone Ayurvedic Pain Killer OilAidrone Pain Relief Oil
Beyond the preview
Go deeper on AIDRONE Oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AIDRONE Oil.